We have located links that may give you full text access.
Journal Article
Review
Treatment of Fetal Supraventricular Tachycardia.
Current Treatment Options in Cardiovascular Medicine 2017 January
Fetal arrhythmia is a common reason for referral to fetal cardiology. Fetal supraventricular tachycardia can be subdivided into several groups with the most common being re-entrant supraventricular tachycardia and atrial flutter. Fetal tachycardia can lead to hydrops fetalis, which increases the risk of fetal demise, perinatal morbidities, and premature delivery. The diagnosis of fetal tachycardia can be a challenge as a traditional electrocardiogram cannot be completed on a fetus, and other methods must be used by fetal echocardiogram. Several retrospective studies have been completed to determine the best treatment; however, there continues to be no consensus on the best option. Digoxin, flecainide, and sotalol are commonly used and have favorable results depending on gestational age, fetal well-being, and presence of hydrops. Treatment in a timely manner can convert supraventricular tachycardia to a normal fetal heart rate, and hydrops can resolve with delivery at term if the proper medications are used.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app